FLGT logo

FLGTFulgent Genetics Inc

$18.47
$0.10
(0.53%)
Today
Closed $18.68
$0.21
(1.12%)
After Hours
Updated: 06:38 PM EDT
EarningsJul 31
Mkt Cap$533.36M
Vol218,773.00
News
all
press releases
Fulgent Presents Updated FID-007 Data at ASCO 2026
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent or the Company), a technology-based company with established laboratory services and therapeutic development businesses, today announced it presented updated data in the Head and Neck Cancer Track during the American Society of Clinical Oncology (ASCO...
Business Wire
News Placeholder
More News
News Placeholder
Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent or the Company), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that its full abstract has been released on the ASCO 2026 website. The abstract will be presented...
Business Wire
News Placeholder
Fulgent Genetics Q1 Earnings Call Highlights
Fulgent Genetics (NASDAQ:FLGT) reported first-quarter 2026 revenue of $71.1 million as the company worked through a planned decline in testing volumes from its largest customer while integrating the...
MarketBeat
News Placeholder
Full Transcript: Fulgent Genetics Q1 2026 Earnings Call
read more...
Benzinga
News Placeholder
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Beats Revenue Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of -89.47% and +4.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Fulgent Genetics (NASDAQ:FLGT) Releases FY 2026 Earnings Guidance
Fulgent Genetics (NASDAQ:FLGT) updated its FY 2026 earnings guidance. The company provided EPS guidance of -1.590--1.590 for the period, compared to the consensus estimate of -1.590. The company also...
MarketBeat
News Placeholder
Fulgent Reports First Quarter 2026 Financial Results
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent, or the Company), a technology-based company with a well-established laboratory services business and a therapeutic development business, today...
Business Wire
News Placeholder
iRhythm Holdings, Inc. (IRTC) Reports Q1 Loss, Tops Revenue Estimates
IRHYTHM HLDGS (IRTC) delivered earnings and revenue surprises of +37.78% and +2.87%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Fulgent Genetics (FLGT) to Release Earnings on Friday
Fulgent Genetics (NASDAQ:FLGT) will be releasing its Q1 2026 earnings before the market opens on Friday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-1-fulgent-genetics-inc-stock...
MarketBeat
News Placeholder
Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Rating of "Hold" by Analysts
Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) have been assigned an average recommendation of "Hold" from the five analysts that are covering the company, MarketBeat reports. One...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.